Universal Health Services is a prominent healthcare management company that operates a diverse portfolio of facilities across the United States and Puerto Rico. The company specializes in providing comprehensive behavioral health services, including inpatient and outpatient care, as well as a wide range of acute care hospital services. UHS focuses on delivering high-quality, accessible healthcare through its network of hospitals and treatment centers, catering to various patient needs while emphasizing innovation and excellence in care. With a commitment to improving health outcomes and enhancing patient experiences, Universal Health Services plays a vital role in the healthcare industry. Read More
Hospital management company Universal Health Services (NYSE:UHS) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 13.4% year on year to $4.50 billion. The company’s full-year revenue guidance of $17.38 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $5.69 per share was 15.4% above analysts’ consensus estimates.
As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top S&P500 gainers and losers shaping the post-market sentiment.
Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities.
However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.
In a landmark development set to redefine diagnostic reporting and regulatory adherence in the medical field, Smart Reporting announced yesterday, October 16, 2025, its definitive agreement to acquire Fluency for Imaging. This strategic merger will culminate in the formation of a new entity, JacobianTM, poised to become a dominant force in AI-powered radiology reporting and [...]
The U.S. labor market is flashing clear signs of weakness as of October 2025, prompting a significant shift in the Federal Reserve's monetary policy. With unexpected job losses and a rising unemployment rate, investors are now betting heavily on continued interest rate cuts, shaping a complex narrative of market
Universal Health Services (UHS) is a leading healthcare provider that appears significantly undervalued. With strong profitability and financial health, it presents a compelling opportunity for value investors.
New York, NY – October 1, 2025 – In a surprising turn of events on Wall Street today, the healthcare sector emerged as the undisputed leader, shrugging off the dual anxieties of a U.S. government shutdown and a disappointing jobs report. As investors sought refuge in defensive plays and reacted to
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer.
However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability.
But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Universal Health Services (UHS) is a value stock with strong fundamentals. It trades at a low P/E ratio, boasts high profitability, solid financial health, and positive growth prospects, indicating potential undervaluation.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how hospital chains stocks fared in Q2, starting with Universal Health Services (NYSE:UHS).
Hospital management company Universal Health Services (NYSE:UHS) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 9.6% year on year to $4.28 billion. The company expects the full year’s revenue to be around $17.2 billion, close to analysts’ estimates. Its non-GAAP profit of $5.35 per share was 8.4% above analysts’ consensus estimates.
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%.
But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Universal Health Services (UHS) is a strong value stock with low P/E, solid profitability, and steady growth, making it an attractive pick for value investors.
